HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer

Li, Weiting; Li, Yongwen; Zhang, Hongbing; Liu, Minghui; Gong, Hao; Yuan, Yin; Shi, Ruifeng; Zhang, Zihe; Liu, Chao; Chen, Chen; Liu, Hongyu; Chen, Jun

doi:10.7150/jca.56093



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2021; 12(18):5562-5572. doi:10.7150/jca.56093 This issue Cite

Research Paper

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer

Weiting Li^1#, Yongwen Li^2#, Hongbing Zhang^1#, Minghui Liu¹, Hao Gong¹, Yin Yuan¹, Ruifeng Shi¹, Zihe Zhang¹, Chao Liu¹, Chen Chen², Hongyu Liu^2✉, Jun Chen^1,2✉

1. Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
2. Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
^#These authors contributed equally in this work.

Citation:

Li W, Li Y, Zhang H, Liu M, Gong H, Yuan Y, Shi R, Zhang Z, Liu C, Chen C, Liu H, Chen J. HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. J Cancer 2021; 12(18):5562-5572. doi:10.7150/jca.56093. https://www.jcancer.org/v12p5562.htm

Other styles

Abstract

The long non-coding RNA Hox transcript antisense intergenic RNA (HOTAIR) plays a critical role in tumorigenesis as well as drug resistance in various cancers. However, the molecular mechanism by which HOTAIR induces gefitinib resistance in non-small cell lung cancer is to date unclear. In the present study, we revealed that HOTAIR is upregulated in gefitinib-resistant lung cancer cells and over-expression of HOTAIR enhances gefitinib resistance in lung cancer cells. In addition, the overexpression of HOTAIR promotes cell cycle progression through epigenetic regulation of EZH2/H3K27. Silencing of EZH2 by either siRNA or inhibitors sensitized the lung cancer cells to gefitinib. Inhibition of EZH2 induces expression of p16 and p21, whereas levels of CDK4, cyclinD1, E2F1, and LSD1 are significantly decreased in PC-9 cells overexpressing HOTAIR. ChIP-PCR experiments indicate that HOTAIR increases H3K27me3 recruitment to the promoter of p16 and p21 in PC-9 lung cancer cells overexpressing HOTAIR. In xenograft mouse models, overexpressing HOTAIR in lung cancer tissues decreased p16 and p21 proteins. Taken together, these data suggest that HOTAIR contributes to gefitinib resistance by regulating EZH2 and p16 and p21. Targeting HOTAIR may be a novel therapeutic strategy for treating gefitinib-resistance in non-small cell lung cancer.

Keywords: Lung cancer, HOTAIR, Gefitinib resistance, EZH2

Citation styles

APA

Li, W., Li, Y., Zhang, H., Liu, M., Gong, H., Yuan, Y., Shi, R., Zhang, Z., Liu, C., Chen, C., Liu, H., Chen, J. (2021). HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. Journal of Cancer, 12(18), 5562-5572. https://doi.org/10.7150/jca.56093.

ACS

Li, W.; Li, Y.; Zhang, H.; Liu, M.; Gong, H.; Yuan, Y.; Shi, R.; Zhang, Z.; Liu, C.; Chen, C.; Liu, H.; Chen, J. HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. J. Cancer 2021, 12 (18), 5562-5572. DOI: 10.7150/jca.56093.

NLM

CSE

Li W, Li Y, Zhang H, Liu M, Gong H, Yuan Y, Shi R, Zhang Z, Liu C, Chen C, Liu H, Chen J. 2021. HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. J Cancer. 12(18):5562-5572.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.